Risk factors

Four new risks center on the pending Transocean combination, including completion uncertainty, deal-related disruption, limited alternatives and interim operating restrictions.

Growth plans now carry explicit risk from higher employee and technology spending whose benefits may be delayed or never materialize.

Newly highlights tariff escalation and retaliation risks that could raise costs or reduce demand for Veralto’s products and services.

New disclosures highlight liquidity needs, inflation exposure and the sensitivity of insurance pricing to medical trends, including gene therapies and chronic conditions.

New risk highlights major infrastructure investment to serve proposed large-scale data-center customers, with VLC and Bespoke tariffs awaiting PSCW approval.

New risks highlight country-level restrictions and instability that could interrupt Western Union services, and AI-related compliance and operational exposure.

The U.S. sales-force shift from independent distributors to employees could disrupt coverage, lose key sellers and reduce sales.

The real-estate loan representations-and-warranties risk is no longer listed.

A new risk says share repurchases and dividends can vary with capital, performance, Basel III changes, market conditions and Board decisions.

Counterparty concentration eased: top ten Agricultural Finance institutions fell from 65% to 55% of loan purchase volume; AgVantage balances declined only $0.1 billion.

Tax disclosures now identify Pillar Two adoption in Japan and the UK from 2024 and the 2025 OBBBA, with guidance expected in 2026.

The 2026 Notes were fully settled in January 2026 with cash on hand; the remaining note-related risks focus on the 2029 Notes.